Alle verbonden artikelen

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Auteurs : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Jaar : 2012
Journal : Lung Cancer
Volume : 77(3)
Pagina's : 605-610

Clinical trial design in head and neck cancer: from past experiences to future perspectives.

Auteurs : de Castro G Jr, Henrique dos Anjos C, Lalami Y, Awada A
Jaar : 2012
Journal : Clinical Investigation
Volume : 2(5)
Pagina's : 473-481

Breast cancer: Should we assess HER2 status by Oncotype DX?

Auteurs : Ignatiadis M, Sotiriou C
Jaar : 2011
Journal : Nat Rev Clin Oncol
Volume : 9(1)
Pagina's : 12-4

Validation and comparison of several published prognostic systems for patients with small cell lung cancer.

Auteurs : Paesmans M, Lafitte JJ, Lecomte J, Berghmans T, Efremidis A, Giner V, Van Cutsem O, Scherpereel A, Meert AP, Leclercq N, Van Houtte P, Sculier JP
Jaar : 2011
Journal : Eur. Respir. J.
Volume : 38(3)
Pagina's : 657-63

Facteurs pronostiques et prédictifs de la réponse un traitement. Invited chapter in “Méthodes biostatistiques appliquées la recherche clinique en cancérologie”. (TEXTBOOK Edited by A. Kramar A. and S. Mathoulin-Pelissier. John Libbey Eurotext)

Auteurs : Paoletti X, Mathoulin-Pelissier S, Michiels S
Jaar : 2011
Journal : Book
Volume : -
Pagina's : -

Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).

Auteurs : Altintas S, Toussaint J, Durbecq V, Lambein K, Huizing MT, Larsimont D, Van Marck E, Vermorken JB, Tjalma WA, Sotiriou C
Jaar : 2011
Journal : Breast J
Volume : 17(4)
Pagina's : 343-51

Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?

Auteurs : Klastersky J, Awada A
Jaar : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pagina's : 17-23

Strategies for subtypes – dealing with the diversity of breast cancer:Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early breast cancer 2011.(+ Panel Members)

Auteurs : Goldhirsch A, Wood WC, Coates AS, Gelber Rd, Thurliman B, Senn HJ, + collaborators (among others :, Piccart-Gebhart M
Jaar : 2011
Journal : Ann Oncol
Volume : 22(8)
Pagina's : 1736-47

Introduction to Gene Expression Profiling In Breast Cancer in “Breast Surgical techniques and Interdisciplinary Management”, (TEXTBOOK Dirbas FM. & Scott-Conner C.E.H. Editors (Springer, 2011 - 440 pages).

Auteurs : Dirbas FM, Sotiriou C
Jaar : 2011
Journal : Book
Volume : -
Pagina's : -

Sculier J-P. Anticancer treatment for advanced non-small cell lung cancer.

Auteurs : Sculier JP
Jaar : 2011
Journal : Breathe
Volume : 8(2)
Pagina's : 125-133

Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.

Auteurs : Rothé F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, Majjaj S, Badran B, Fayyad-Kazan H, Desmedt C, Harris AL, Piccart-Gebhart M
Jaar : 2011
Journal : PLoS One
Volume : 6(6)
Pagina's : e20980

Inaugural bilateral aspergillus endophthalmitis in a seriously immunocompromised patient.

Auteurs : Georgala A, Layeux B, Kwan J, Ahmad I, Libert J, Willermain F, Koch P, Heymans C, Husson M, Aoun M
Jaar : 2011
Journal : Mycoses
Volume : 54 (5)
Pagina's : e631-3

Prevention of neutropenia-related events in elderly patients with haematological cancer

Auteurs : Klastersky J, Gombos A, Georgala A, Awada A
Jaar : 2011
Journal : Aging Health
Volume : 7(6)
Pagina's : 829-42

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Auteurs : Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D
Jaar : 2011
Journal : J Thorac Oncol
Volume : 6(2)
Pagina's : 244-85

Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.

Auteurs : Michiels S, Potthoff RF, George SL
Jaar : 2011
Journal : Stat Med
Volume : 30(13)
Pagina's : 1502-18

Thoracic Oncology, in European Respiratory roadmap, recommendations for the future of respiratory medicine

Auteurs : Sculier JP
Jaar : 2011
Journal : ERS
Volume : -
Pagina's : 60-63

Gene profiling assay and application: the predictive role in primary therapy.

Auteurs : Fumagalli D, Desmedt C, Ignatiadis M, Loi S, Piccart-Gebhart M, Sotiriou C
Jaar : 2011
Journal : J. Natl. Cancer Inst. Monographs
Volume : 2011(43)
Pagina's : 124-7

Febrile neutropenia: a critical review of the initial management.

Auteurs : Klastersky J, Awada A, Paesmans M, Aoun M
Jaar : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(3)
Pagina's : 185-94

A late complication of percutaneous radial artery cannulation.

Auteurs : Nazeri A, Schawon S, Papadopoulou B, Georgala A, Dernier Y, Noordally SO
Jaar : 2011
Journal : Acta Clin Belg
Volume : 66 (3)
Pagina's : 223-5

The 12th Annual Conference on Thoracic Oncology].

Auteurs : Sculier JP
Jaar : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pagina's : 114-5